Iteos Therapeutics Inc (ITOS)
Iteos Therapeutics Inc (ITOS)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 03-2024 | 12-2023 | 09-2023 | 06-2023 | 03-2023 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 146,648 | 251,177 | 204,134 | 216,213 | 225,361 |
| Marketable Securities | 302,496 | 280,739 | 394,893 | 383,011 | 376,776 |
| Receivables | 5,920 | 6,500 | 6,312 | 3,683 | 668 |
| TOTAL | $480,386 | $550,652 | $619,128 | $614,547 | $615,401 |
| Non-Current Assets | |||||
| PPE Net | 5,264 | 4,696 | 3,330 | 2,548 | 2,119 |
| Investments And Advances | 132,587 | 100,539 | 45,897 | 78,260 | 104,484 |
| Other Non-Current Assets | 11,532 | 11,701 | 9,289 | 8,391 | 6,342 |
| TOTAL | $149,383 | $116,936 | $58,516 | $89,199 | $112,945 |
| Total Assets | $629,769 | $667,588 | $677,644 | $703,746 | $728,346 |
| Liabilities | |||||
| Current Liabilities | |||||
| Accounts payable and accrued liabilities | 11,595 | 21,080 | 3,419 | 5,227 | 5,694 |
| Accrued Expenses | 21,523 | 15,620 | 22,049 | 21,247 | 17,727 |
| TOTAL | $35,558 | $40,014 | $28,223 | $30,023 | $26,358 |
| Non-Current Liabilities | |||||
| Deferred Revenues | 1,178 | 2,063 | 1,638 | 2,528 | 2,073 |
| Other Non-Current Liabilities | 53,011 | 52,346 | 51,159 | 50,197 | 49,726 |
| TOTAL | $53,011 | $52,346 | $51,159 | $50,197 | $49,726 |
| Total Liabilities | $88,569 | $92,360 | $79,382 | $80,220 | $76,084 |
| Shareholders' Equity | |||||
| Shares Outstanding, K | 36,123 | 35,843 | 35,785 | 35,782 | 35,764 |
| Common Shares | 36 | 36 | 36 | 36 | 36 |
| Retained earnings | 86,417 | 124,633 | 155,183 | 187,424 | 221,724 |
| Other shareholders' equity | -16,337 | -13,240 | -13,256 | -13,166 | -11,548 |
| TOTAL | $541,200 | $575,228 | $598,262 | $623,526 | $652,262 |
| Total Liabilities And Equity | $629,769 | $667,588 | $677,644 | $703,746 | $728,346 |